Shaking Up the Gin and Tonic |
Phone Companies Sell Customers’ Location Info |
‘Unlimited’ Vacation Gains Popularity |
Widow of Steve Jobs Steps Into Philanthropy Spotlight |
A Second Look at Eyelash Drug
Written by Pat's Papers | Thursday, 29 October 2009 6:48 PM
I’ve seen the ads “? and the long list of disclaimers - for this product and wondered the same thing Julie Deardorff of the Chicago Tribune asks in this morning’s paper: Is an eyelash drug worth the risk? Deardorff writes that while Latisse, a product for “inadequate eyelashes,” might be wonderful for people who have undergone chemotherapy, the commercial “embodies pretty much everything that’s wrong with direct-to-consumer advertising.”
SOURCE: All others
Email this story
Enter address below to get the morning headlines in your inbox (more details)
New on the Blog
What if ‘In the Papers’ Became ‘In the Women’s Magazines?’
Ali Wentworth asked Pat to do a NY1-style summary of some headlines from Cosmo and Self magazines during their Q and A.
- 5/16 Memo to Women of NYC: Topless OK
- 5/21 ‘Monstrous’ Twister Devastates Oklahoma
- 5/23 Jeter’s Starbucks Alter Ego: ‘Philip’
- 5/10 Attention-Grabbers Top Most Popular Name List
- 5/20 ‘Unlimited’ Vacation Gains Popularity
Favorites
U.S. Newspapers
- USA Today
- Wall Street Journal
- New York Times
- LA Times
- New York Daily News
- New York Post
- Washington Post
- Chicago Tribune
- Houston Chronicle
- San Francisco Chronicle
- Dallas Morning News
- Boston Globe
- Philadelphia Inquirer
- Cleveland Plain-Dealer
- Chicago Sun-Times
- Kansas City Star
- Miami Herald
- San Jose Mercury News
- Baltimore Sun
- Denver Post
- Seattle Times
- Milwaukee Journal Sentinel
- Oklahoman
- Detroit News
- Boston Herald
- Omaha World Herald
- Commercial Appeal
International Newspapers
- International Herald Tribune
- The Times of London
- The Guardian
- The Daily Mail
- The Australian
- Irish Times
- Straits Times
- South China Morning Post
- The Times of India
- The Globe and Mail
blog comments powered by Disqus